VIDEO: Likeliness of atypical antipsychotics causing TD

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify iwaters@healio.com if there are concerns regarding accuracy of the transcription.

In my field of movement disorders, we see a fair amount of tardive dyskinesia and it's a referral bias, right? So when patients develop tardive, the patients come to us and that's why we see a disproportionate amount. But I do realize that it's rare enough in the general community that it's very easy to not really think about TD as a possible use of these antipsychotics. You know, there's been in the psychiatric field, a lot of new atypical antipsychotics that have come out in the market and they have the promise of being less likely to cause tardive dyskinesia but the truth is they all can do it. So, I think it's important to emphasize that the belief that the atypical antipsychotics don't cause tardive, it's important to, sort of, point out that they can. And of course, the rates are not as high as with the typical antipsychotics, but still, you know, if you are the patient who develops tardive, even if it's a rare occurrence, you still don't want to be in that position. So I think it's important to just have a honest conversation with our patients. If we do prescribe these medications, I think it's important to educate the patient that this is a real possibility. And I think that also will allow the patient to screen himself or herself, for the emergence of these symptoms. And actually, if it's something that they're looking for, they might be able to detect it sooner and just bring it to the attention of the person who's prescribing the agent. So, it really works in everybody's advantage to have a, sort of, very direct conversation that the side effects can happen with, essentially, any of the antipsychotics that we use.